Michelle_Hutchinson comments on How much further does your dollar go overseas? - Effective Altruism Forum

You are viewing a comment permalink. View the original post to see all comments and the full post content.

Comments (5)

You are viewing a single comment's thread.

Comment author: Michelle_Hutchinson 05 February 2018 02:48:52PM 2 points [-]

[Note: It is difficult to compare the cost effectiveness of developed country anti-smoking MMCs and developing country anti-smoking MMCs because the systematic review cited above did not uncover any studies based on a developing country anti-smoking MMC. The one developing country study that it found was for a hypothetical anti-smoking MMC. That study, Higashi et al. 2011, estimated that an anti-smoking MMC in Vietnam would result in one DLYG (discount rate = 3%) for every 78,300 VND (about 4 USD). Additionally, the Giving What We Can report that shows tobacco control in developing countries being highly cost effective is based on the cost-effectiveness of tobacco taxes, not the cost-effectiveness of anti-smoking MMCs, and the estimated cost-effectiveness of tobacco taxes is based on the cost to the government, not the cost to the organization lobbying for a tobacco tax.]

This report briefly discusses MMCs as well as tax increases. It mentions MMCs are likely to be much more effective than those in the UK, due to the comparatively far lower awareness of the harms of smoking in developing countries, and far higher incidences in smoking. I wonder if we could learn more about the potential efficacy of such campaigns by comparing them to campaigns to try to lower road traffic injury? My impression is that in the latter case there has been a bit more study done specifically in developing world contexts.

Comment author: John_Maxwell_IV 10 February 2018 06:59:01AM *  0 points [-]

Yeah, my hunch is that in developed countries, it's higher-leverage to help people quit than spread awareness of smoking harms. For example, there's a supplement called NAC that might help. (I assume that no large trials have been done because no pharmaceutical company can patent it.) Making e-cigarettes easier to get could also be a good idea.